Lacee Meyer
Geriatric Medicine · Bellevue, WANPI 1689448870
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 50.4% of the total. Among geriatric medicine clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 81 payments — averaging $36.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Antares Pharma, Inc.$202
- Aimmune Therapeutics, Inc.$148
- Gilead$142
- Axsome Therapeutics, Inc.$118
- Pfizer$92
- plus $758 from 18 others
What the payments were for
- Food & beverage$2,942100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 22 | $1,482 |
| Antares Pharma, Inc. | 13 | $202 |
| Aimmune Therapeutics, Inc. | 6 | $148 |
| Gilead | 2 | $142 |
| Axsome Therapeutics, Inc. | 1 | $118 |
| Pfizer | 4 | $92 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $90 |
| Neuronetics, Inc. | 4 | $90 |
| Lilly USA, LLC | 4 | $88 |
| Novo Nordisk | 3 | $79 |
| Corium, LLC | 2 | $53 |
| Johnson & Johnson | 2 | $46 |
| Bausch Health US, LLC | 2 | $43 |
| Verity Pharmaceuticals Inc. | 2 | $40 |
| Braeburn Inc. | 1 | $28 |
| Exact Sciences | 1 | $28 |
| Edwards Lifesciences | 1 | $27 |
| AstraZeneca | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Si-bone, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Novartis | 1 | $21 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,942 in reported general payments places this provider in the 90th percentile of 77 geriatric medicine providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 12 | $627 |
Paid to pharmacies, not to this prescriber.
Other geriatric medicine in Bellevue
- Richard KanerBellevue$5K
- Daniel RaskindBellevue$983
- Benjamin PintoBellevue$890
- Priyanka DuggalBellevue$388
- Genevie MoranBellevue$0
- John Dugawla Conner$34K
- Angela HansonSeattle$12K
- Neeti MittalMercer Island$7K
- Sabine von Preyss-FriedmanSeattle$3K
- Suzanne StaudingerBenton City$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.